RedHill will receive an initial payment from Hyloris and could earn up to $60 million based on certain achievements. If applicable, the deal may involve medications like Talicia or Aemcolo.
Idorsia, a pharmaceutical company, couldn’t secure a buyer, so it changed a current partnership and reorganized its financial agreements to get more money.
The Phase III DIAMOND trial successfully achieved its main and additional goals of reducing tics in both children and adults. Some medications involved in such trials might include names like aripiprazole or risperidone, though specific names from this trial aren’t mentioned.
Eikon’s main drug, EIK1001, is currently being tested in a Phase III trial to treat melanoma, a type of skin cancer. It is being used in combination with Keytruda, a medicine developed by the company MSD.
The company’s decision boosts its total investment promises in the U.S. to over $50 billion since 2020. Unfortunately, the text doesn’t provide specific names of pills or medications.
This treatment is for people whose illness got worse after they tried chemotherapy drugs that contain platinum. Some examples of these chemotherapy drugs are cisplatin and carboplatin.
The FDA will decide whether to approve odronextamab, a treatment for relapsed or hard-to-treat follicular lymphoma, by July 30, 2025. If approved, it would join other medications like Rituxan and Gazyva, which are also used to treat this condition.
The pharmaceutical industry is highly competitive, which has led to a big increase in healthcare advertising, with spending expected to
Astellas and Apellis are competing for market share in the U.S. for their geographic atrophy (GA) treatments, Izervay and Syfovre.
Here’s a simplified version of the text: There’s a rare heart condition known as transthyretin amyloidosis cardiomyopathy that has caught
